Alto Neuroscience rallies over $40m
Alto Neuroscience, a provider of a clinical-stage pipeline of precision psychiatry medicines, has raised over $40 million in funding.
Alto Neuroscience, a provider of a clinical-stage pipeline of precision psychiatry medicines, has raised over $40 million in funding.
Copyright PEI Media
Not for publication, email or dissemination
